Metabolomics in the Diagnosis and Treatment of Asthma in Children
ConditionAsthma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-17
SponsorI.M. Sechenov First Moscow State Medical University
About this trial
The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is:
• Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.
Eligibility criteria
Qualifiers
Age from 12 to 17 years old
Confirmed diagnosis of asthma
Informed voluntary consent to participate in the study
Disqualifiers
age under 12 years
no established diagnosis of asthma
concomitant severe somatic, metabolic, and endocrine diseases
patient's withdrawal of informed consent
Trial design
Treatments tested in this trial
- Standart medical treatment
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov